BE901433A - Composition pharmaceutique stable pour le traitement de la cetose et procede pour la preparer. - Google Patents

Composition pharmaceutique stable pour le traitement de la cetose et procede pour la preparer.

Info

Publication number
BE901433A
BE901433A BE1/11164A BE1011164A BE901433A BE 901433 A BE901433 A BE 901433A BE 1/11164 A BE1/11164 A BE 1/11164A BE 1011164 A BE1011164 A BE 1011164A BE 901433 A BE901433 A BE 901433A
Authority
BE
Belgium
Prior art keywords
ketosis
preparing
treatment
pharmaceutical composition
same
Prior art date
Application number
BE1/11164A
Other languages
English (en)
Original Assignee
Egyt Gyogyszervegyeszeti Gyar
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Egyt Gyogyszervegyeszeti Gyar filed Critical Egyt Gyogyszervegyeszeti Gyar
Publication of BE901433A publication Critical patent/BE901433A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/143—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Fodder In General (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Saccharide Compounds (AREA)

Abstract

Cette composition qui comprend du propionate de calcium, de la dextrose et du propylène glycol, se caractérise en ce que ce dernier est lié à un support solide consistant en oxyde de magnésium, carbonate de magnésium, peroxyde de magnésium et/ou silice, la quantité de support étant dans la gamme de 33 à 300 % en poids par rapport au propylène glycol.
BE1/11164A 1984-01-06 1985-01-03 Composition pharmaceutique stable pour le traitement de la cetose et procede pour la preparer. BE901433A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU8440A HU191245B (en) 1984-01-06 1984-01-06 Process for the production of stbale pharmaceutical preparation against ketosis

Publications (1)

Publication Number Publication Date
BE901433A true BE901433A (fr) 1985-07-03

Family

ID=10947613

Family Applications (1)

Application Number Title Priority Date Filing Date
BE1/11164A BE901433A (fr) 1984-01-06 1985-01-03 Composition pharmaceutique stable pour le traitement de la cetose et procede pour la preparer.

Country Status (6)

Country Link
JP (1) JPS60214747A (fr)
BE (1) BE901433A (fr)
DE (1) DE3500187A1 (fr)
FR (1) FR2565105B1 (fr)
GB (1) GB2153670B (fr)
HU (1) HU191245B (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2202742B (en) * 1987-03-26 1990-11-28 Univ London Preventing adp-ribosylation of g-proteins
EP0491754A4 (en) * 1989-09-15 1992-08-12 Cima Labs, Inc. Magnesium carbonate and oil tableting aid
US5601836A (en) * 1993-06-28 1997-02-11 Great Lakes Biochemical Company, Inc. Nutritional supplement for calving ruminant animals
GB9418420D0 (en) * 1994-09-13 1994-11-02 Mckeown Neil A Composition for the treatment of an energy imbalance in ruminents
US5560920A (en) * 1995-04-07 1996-10-01 The United States Of America, As Represented By The Secretary Of Agriculture Calcium formulations for prevention of parturient hypocalcemia
WO1998042205A1 (fr) 1997-03-21 1998-10-01 Basf Aktiengesellschaft Solutions a base d'acide propionique, d'ammoniaque, de propanediol et leur utilisation
US6126986A (en) * 1999-02-23 2000-10-03 Westway Trading Corporation Process for formulating a liquid animal feed ingredient containing sugar and neutralized carboxylic acid
CN104922064B (zh) * 2015-05-28 2019-01-29 广东温氏大华农生物科技有限公司 一种防治奶牛酮病的纳米级营养微乳液及其制备方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE156999C (fr) * 1902-04-02
US3196073A (en) * 1961-03-16 1965-07-20 Dow Chemical Co Method of tranquilizing with 1, 2-dihydroxy propane
FR1546819A (fr) * 1967-01-14 1968-11-22 Union Agricole Ag Fuer Landw S Procédé pour l'alimentation d'appoint de vaches laitières de haut rendement, en particulier avant et après le vêlage, et aliment d'appoint pour la mise en oeuvre du procédé
US3621163A (en) * 1970-01-19 1971-11-16 Acb Corp Inertia switch
DE2014844C2 (de) * 1970-03-26 1984-09-06 Boliden Ab, Stockholm Verfahren zur Herstellung eines granulierten Magnesiumoxid-Produktes
DE2518189A1 (de) * 1975-04-24 1976-11-04 Astra Ewos Ab Spurenelementkonzentrat, verfahren zu dessen herstellung und dessen verwendung
SE421042B (sv) * 1976-06-29 1981-11-23 Kockums Chem Sett att minska den for en viss biologisk effekt erforderliga mengden biologiskt aktiv substans
JPS5344636A (en) * 1976-10-05 1978-04-21 Mitsubishi Chem Ind Ltd Remedy and prevention for milk fever
GB1596505A (en) * 1976-11-23 1981-08-26 Unilever Ltd Food manufacture
DE3010250A1 (de) * 1980-03-17 1981-09-24 Wolf Freiherr von 8183 Rottach-Egern Tucher Verwendung eines vorkonzentrats als zusatz zu mastfutter fuer saeugetiere
AT372854B (de) * 1981-02-03 1983-11-25 Moser Siegfried Dr Verfahren zur vorbeugung der entstehung gravierender gesundheitlicher stoerungen bei wiederkaeuern sowie zur wildverbissverhinderung
US4486412A (en) * 1983-03-15 1984-12-04 Pharmacaps, Inc. Encapsulated antacid dispersions
HU190866B (en) * 1984-01-06 1986-11-28 Egis Gyogyszergyar,Hu Process for producing concentratum increasing the weight output and containing agent of 1-25 mass pct. and/or animal food containing agent of 0,001-0,075 mass pct.
HU191244B (en) * 1984-01-06 1987-01-28 Egyt Gyogyszervegyeszeti Gyar Dust mixture of high propylene-glycol content and process for producing same

Also Published As

Publication number Publication date
JPH0324450B2 (fr) 1991-04-03
FR2565105A1 (fr) 1985-12-06
HU191245B (en) 1987-01-28
DE3500187A1 (de) 1985-07-18
GB8500143D0 (en) 1985-02-13
HUT37336A (en) 1985-12-28
GB2153670B (en) 1988-03-23
FR2565105B1 (fr) 1988-07-01
JPS60214747A (ja) 1985-10-28
GB2153670A (en) 1985-08-29

Similar Documents

Publication Publication Date Title
OA06914A (fr) Procédé de préparation d'iminodiacides substitués.
DE3764816D1 (de) Brausepaare, h2-antagonisten von histamin enthaltende brausemischungen und verfahren zu ihrer herstellung.
ES272001U (es) Un dispositivo de polea motriz perfeccionado.
BE1003021A3 (fr) Compositions pharmaceutiques agissant en particulier sur le systeme cardiaque et cardiovasculaire et procede pour les preparer.
OA06930A (fr) Procédé de préparation d'acides aza-bicyclo-octane carboxyliques.
BE901433A (fr) Composition pharmaceutique stable pour le traitement de la cetose et procede pour la preparer.
DK315082A (da) Rengoeringsmiddel med aluminiumsilicat-builder og lavt phosphatindhold
OA06973A (fr) Procédé pour préparer enzymatiquement l'acide amino-2 méthylphosphino-4 butiryque- (L).
BE822843A (fr) Procede et agent pour l'activation de cholesterine oxydase
FR2364228A1 (fr) Procede de preparation d'un catalyseur de trichlorure de titane utilisa
AU542960B2 (en) Non irritating tetramisole or levamisole pour on compositions
BE1002428A3 (fr) Compositions pharmaceutiques agissant sur le coeur et le systeme cardiovasculaire et procede pour leur preparation.
CA1262140C (fr) Alcools de 7-oxabicycloheptane prostaglandine substitues
BE887260A (fr) Composition pharmaceutique comprenant un derive de l'acide aminobenzoique pour reguler les prostaglandines
OA06792A (fr) Procédé de préparation de dérivés esters d'acides cyclopropane-carboxylique.
SU694557A1 (ru) Сталь
GR75173B (fr)
FR2575473B1 (fr) Catalyseur homogene de rhodium pour hydrogenation stereospecifique et son application
GB2072661B (en) Saltgs of mixed esters for use as water dilutable metal-working lubricants
FR2642423B1 (fr) Procede de preparation d'alkyldiethanolamides gras purifies, les produits obtenus et leurs utilisations
BE894228A (fr) Composition pharmaceutique pour le traitement de l'atherosclerose
FR2392047A1 (fr) Melange polymerisable de methylvinylbenzenes isomeres
ES2014445B3 (es) Composiciones farmaceuticas que contienen compuestos 5-fenil-1,3-dioxialquenilicos.
OA06793A (fr) Procédé de préparation de dérivés esters d'acides cyclopropane-carboxyliques.
GB1366667A (en) Bicyclic compounds

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: EGYT GYOGYSZERVEGYESZETI GYAR

Effective date: 19970131